[Antagonistic effect of the Fengzhecao extract against human red blood cell hemolysis induced by wasp venom].


Journal

Zhonghua wei zhong bing ji jiu yi xue
ISSN: 2095-4352
Titre abrégé: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
Pays: China
ID NLM: 101604552

Informations de publication

Date de publication:
Feb 2020
Historique:
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 11 7 2020
Statut: ppublish

Résumé

To explore the antagonistic effect of Fengzhecao extract against human red blood cell (RBC) hemolysis induced by wasp venom. Water extract method was used to extract dried Fengzhecao and vacuum-dried to obtain Fengzhecao extract. It was diluted into 1 g/L for next use. Wasp venom was collected from the wasp workers. A, B, O, AB type healthy blood donors' suspended RBC solution was obtain to make washed RBC solutions and adjust the RBCs count (4.0-80.0)×10 There was no statistically significant difference in RBC count between blood types under the same treatment factors. The RBC count (×10 Wasp venom has a significant hemolytic effect which can be effectively antagonized by Fengzhecao extract and has nothing to do with the human ABO blood type.

Identifiants

pubmed: 32275011
doi: 10.3760/cma.j.cn121430-20190930-00042
doi:

Substances chimiques

Drugs, Chinese Herbal 0
Wasp Venoms 0

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

226-229

Auteurs

Yungang Pu (Y)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Renfu Tian (R)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Gang Wu (G)

Department of Blood Transfusion, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Yan Xia (Y)

Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, the Affiliated Minda Hospital of Hubei Minzu University, Enshi 445000, Hubei, China. Corresponding author: Pu Yungang, Email: puyungang@126.com.

Yechao Wang (Y)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Cheng Huang (C)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Shun Zhu (S)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Changjiang Huang (C)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Xi Yang (X)

Department of Critical Care Medicine, the Affiliated Central Hospital of Enshi Autonomous Prefecture of Hubei Minzu University, Enshi 445000, Hubei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH